INNV InnovAge Holding
- 3.880
- +0.330+9.30%
InnovAge Holding News
12 Health Care Stocks Moving In Monday's After-Market Session
GainersGeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings
InnovAge Launches PACE Center in Los Angeles, Helping Seniors Live Independently With High-Quality Care
LOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), the healthcare industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the
InnovAge to Announce Fiscal Third Quarter 2024 Financial Results and Host Conference Call Tuesday, May 7, 2024
DENVER, April 23, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (NASDAQ:INNV), an industry leader in providing comprehensive healthcare programs to frail, and predominantly dual-eligible
InnovAge Holding (NASDAQ:INNV) Has Debt But No Earnings; Should You Worry?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh
InnovAge Is Maintained at Neutral by JP Morgan
InnovAge Is Maintained at Neutral by JP Morgan
Express News | JP Morgan Maintains Neutral on InnovAge Holding, Lowers Price Target to $6
InnovAge Launches First PACE Center in Florida Providing Comprehensive Healthcare Program for Seniors to Promote Independence
TAMPA, Fla., March 04, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge") (NASDAQ:INNV), the industry leader in providing comprehensive healthcare programs to dual-eligible seniors through the Program of
InnovAge Holding: A Cautious Hold Amidst Growth Opportunity and Execution Hurdles
InnovAge Holding Hosts Informative Investor Webcast Event
InnovAge Is Maintained at Neutral by Goldman Sachs
InnovAge Is Maintained at Neutral by Goldman Sachs
Express News | Goldman Sachs Maintains Neutral on InnovAge Holding, Lowers Price Target to $7
InnovAge Holding Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 02/08/2024 36.72% Goldman Sachs $8 → $7 Maintains Neutral 02/15/2023 75.78% Goldman Sachs $8 → $9 Maintain
InnovAge to Host Investor Day on February 27, 2024
DENVER, Feb. 08, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predomi
InnovAge Holding: A Cautious Hold Amidst Mixed Financial Signals
Earnings Call Summary | InnovAge Holding(INNV.US) Q2 2024 Earnings Conference
The following is a summary of the InnovAge Holding Corp. (INNV) Q2 2024 Earnings Call Transcript:Financial Performance:InnovAge reported Q2 revenue of $189 million, an increase of 3.5% compared to Q1.
Recap: InnovAge Holding Q2 Earnings
InnovAge Holding (NASDAQ:INNV) reported its Q2 earnings results on Tuesday, February 6, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsInnovAge Holding reported in-
InnovAge GAAP EPS of -$0.03 In-line, Revenue of $188.89M Beats by $4.88M
InnovAge 2Q Rev $188.9M >INNV
InnovAge 2Q Rev $188.9M >INNV
Earnings Outlook For InnovAge Holding
InnovAge Holding (NASDAQ:INNV) is set to give its latest quarterly earnings report on Tuesday, 2024-02-06. Here's what investors need to know before the announcement.Analysts estimate that InnovAge Ho
InnovAge to Announce Fiscal Second Quarter 2024 Financial Results and Host Conference Call Tuesday, February 6, 2024
DENVER, Jan. 23, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. ("InnovAge" or the "Company") (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, and predomi
Analysis
Price Target
No Data
